Navigation Links
Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds

ginosa: results of the 2005-2006 Surveillance Program. M.K. Aranza, D.C. Draghi, M.E. Jones, C. Thornsberry, D.F. Sahm (Herndon, U.S.; Breda, NL)

P2025 Activity of ceftobiprole against US clinical S. pneumoniae isolates that are ceftriaxone non-susceptible. T. Davies, K. Bush, P. Appelbaum (Raritan, Hershey, U.S.)

P2026 Activity of ceftobiprole against Pseudomonas aeruginosa clinical isolates from Europe collected in 2005-2006. T. Davies, D. Sahm, R. Flamm, K. Bush (Raritan, Herndon, U.S.)

P2027 Ceftobiprole activity and resistance patterns in staphylococcal isolates from a recent complicated skin and skin structure infection study. K. Amsler, M. Jacobs, S. Bajaksouzian, A. Windau, M. Heep, K. Bush (Raritan, Cleveland, U.S.; Basle, CH)

O120 Epidemiology of (CA-) MRSA (Room 13b) Characteristics of complicated skin and skin structure infections due to staphylococci and the presence of Panton-Valentine leukocidin. R. Strauss, K. Amsler, M. Jacobs, K. Bush, G. Noel (Raritan, U.S.)

List of Isavuconazole Presentations

P987 Steady-state bioavailability of oral isavuconazole in healthy volunteers. A. Schmitt-Hoffmann, B. Roos, M. Heep (Basle, CH)

P1675 QTc measurements during a placebo- and actively controlled multiple dose study of two different dosing regimens of isavuconazole. M. Heep, B. Roos, M. Sochor, A. Schmitt-Hoffmann, S. Van Merle, D. Kappers, P. Voiriot (Basle, CH; Zuidlaren, NL; Nancy, FR)

P1676 Evaluation of isavuconazole (BAL8557/BAL4815) Etest compared to broth microdilution antifungal susceptibility testing against quality control strains and fluconazole susceptible clinical Candida isolates. M. Heep, P. Grover, N.P. Brown, D. Sahm, M.E. Jones (Basle, CH; Herndon, U.S.)

P1951 Dose response in neutropenic mice with disseminated infection of multiple strains of Aspergillus fumigatus with widely varying MIC and MFC values treated with isavuconazole.P.A. Warn, A. Parmar, A. Sharp, D.W. Denning (Manc
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
2. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
3. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
6. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
7. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
8. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
9. Inspire Announces Presentations at Two European Scientific Conferences
10. HepaLife Announces Scientific Presentation of PBS-1 Cell Line at International Influenza Meeting
11. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
Post Your Comments:
(Date:10/6/2008)... Conference Call Scheduled for 9:00 AM ET Today -,...on Corporation (Nasdaq:,DNDN) announced today that...the Phase 3, randomized, double-blind, placebo-con...rcinoma Treatment, also known as D9902B),clinical ...f the,investigational active cellular immunotherap...
(Date:10/6/2008)... Procedure May Eliminate 6 Weeks of Radiation Ther...t over the Internet Wednesday, October 22, 2008...xplorehealth , HAMPTON, Va., Oct. 6 /PRNewswire/ ...e was diagnosed with breast cancer in May. Would s...w about radiation or chemotherapy?, , To view th...
(Date:10/6/2008)...ept of Other Product - Company,s Bioabsorbable Ste...ONG KONG, Oct. 6 /- Data from multipl... stent, OrbusNeich,s Genous Bio-engineered R,stent... Cardiovascular,Therapeutics symposium, TCT 2008, ...D., of the Academic Medical Center in,Amsterdam wi...
(Date:10/5/2008)...blished in New England Journal of Medicine reaffir...rofile of SPIRIVA(R),HandiHaler(R), RIDGEFIELD, C... of the,UPLIFT (Understanding Potential Long-term ... that SPIRIVA(R) HandiHaler(R) (tiotropium bromide...g function for up to 4,years as measured by FEV(1)...
Breaking Medicine Technology:Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6AARP Maryland Key Vote News Alert 21748 1AARP Maryland Key Vote News Alert 21748 2AARP Maryland Key Vote News Alert 21748 3Biopure Granted Additional 180 Day Compliance Period by NASDAQ 5972 1Biopure Granted Additional 180 Day Compliance Period by NASDAQ 5972 2XTENT Announces European Regulatory Update 2414 1XTENT Announces European Regulatory Update 2414 2XTENT Announces European Regulatory Update 2414 3JCI online early table of contents 3A June 12 2008 21746 1JCI online early table of contents 3A June 12 2008 21746 2JCI online early table of contents 3A June 12 2008 21746 3JCI online early table of contents 3A June 12 2008 21746 4JCI online early table of contents 3A June 12 2008 21746 5JCI online early table of contents 3A June 12 2008 21746 6JCI online early table of contents 3A June 12 2008 21746 7
(Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
(Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
(Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
(Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3
...chnique to find out if metastasis from the eye can... research scientists at Washington University Scho...for the prediction of whether melanoma of the eye ...kly transform into being very lethal. The scientis...
...al age for buying cigarettes in Scotland to 18 yea...or NHS Scotland has led a team of experts //who ar...h Executive. Health Minister Andy Kerr said that s...ts do not take up the habit. "We must get a strong...
Overseas Trained Nurses To Be Allowed To Retrain For Scottish Jobs
...le can be a common feature but could be prevented.... System//, have stated that many a times the simpl... shower, for older people could turn out to be a d...eature. The study that appears in the Journal of ...
Other Medicine News:Health News:Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated 2Health News:Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated 3Health News:Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated 4Health News:Common Falls In Bath Among Older Adults Can Be Prevented 2Health News:Common Falls In Bath Among Older Adults Can Be Prevented 3
Para 12 Plus is a hematology control for the Abbott CELL-DYN 3000, 3200, and 3500/3700. Assay values are provided for the five-part white cell differential, as well as a three-part differential on th
Indicated to facilitate the intra-luminal placement of conventional guidewires beyond stenotic lesions, including chronic total coronary occlusions.
... 5X is a whole blood hematology control manufactur...0, and the Coulter AcT5diff instruments. The compo...differential, positioning the populations within t...he product offers 105-day closed-vial stability an...
...-Chex is a spinal and body fluid control with dist... the same manner as a patient sample, the white bl...trol is assayed for manual cell counting, the five...e two-part polymorphonuclear and mononuclear diffe...
Medicine Products: